N@N

Somaxon Pharmaceuticals to Present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference

^{Published on 2010-07-29 05:16:06 - Market Wire}
 

SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer, will present at the BMO Capital Markets 10^th Annual Focus on Healthcare Conference at The Sheraton New York Hotel and Towers in New York City on Thursday, August 5th at 10:45 a.m. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the companya™s Web site under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for 6 months following the conference.

About Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona™s product Silenor® (doxepin) has been approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance.

For more information, please visit the companya™s web site at [ www.somaxon.com ].